Smith+Nephew maintain guidance as it lifts profits and cash flow, launches $500 million buyback after strong first half

Smith+Nephew reported robust first-half results, with revenue up 4.7% to $2.96 billion and operating profit surging 30.6% to $429 million, alongside a significant improvement in cash generation with free cash flow rising to $244 million. The medical technology company maintained its full-year guidance for revenue and profit margin, while announcing a $500 million share buyback for the second half of 2025, reflecting confidence in its financial strength and the success of its operational improvements.

Analysis

Smith+Nephew's first-half 2025 results demonstrate significant operational and financial momentum, validating its strategic initiatives. The company reported a 4.7% rise in H1 revenue to $2.96 billion, with an acceleration in the second quarter to 6.7% underlying growth, driven by strong performance across all three business units. Notably, the Advanced Wound Management division rebounded with 10.2% underlying growth. Profitability saw a substantial uplift, with the operating profit margin expanding to 14.5% from 11.6% a year prior, leading to a 30.6% surge in operating profit. The most compelling evidence of operational improvement lies in cash generation; free cash flow increased dramatically to $244 million from just $39 million in the prior year, and trading cash conversion improved to 93% from 60%. This robust financial health underpins the announcement of a new $500 million share buyback and a 4.2% increase in the interim dividend. Management's confidence is further underscored by the reaffirmation of full-year guidance, which includes an expected trading profit margin of 19.0% to 20.0%, suggesting the positive trends are anticipated to continue.

Key Decisions for Investors

• Consider the strong H1 performance, particularly the 30.6% operating profit growth and surge in free cash flow to $244 million, as tangible evidence that the company's operational turnaround under the 12-Point Plan is delivering material results.
• Evaluate the new $500 million share buyback and the 4.2% dividend increase as strong signals of management's confidence in sustained cash generation and a commitment to enhancing shareholder returns.
• Monitor the company's ability to achieve its full-year trading profit margin guidance of 19.0-20.0%, which would require continued momentum, and track the performance of new product launches, which were the primary driver of first-half growth.